Abstract:Background-Oxidative stress, an excessive production of reactive oxygen species (ROS) outstripping antioxidant defense mechanisms, occurs in cardiovascular pathologies, including hypertension. In the present study, we used biochemical, physiological, and pharmacological approaches to explore the role of derangements of catecholamines, ROS, and the endothelium-derived relaxing factor nitric oxide (NO center dot) in the development of a hyperadrenergic model of hereditary hypertension: targeted ablation (knockout [KO]) of chromogranin A (Chga) in the mouse.Methods and Results-Homozygous (-/-) Chga gene knockout (KO) mice were compared with wild-type (WT, +/+) control mice. In the KO mouse, elevations of systolic and diastolic blood pressure were accompanied by not only elevated catecholamine (norepinephrine and epinephrine) concentrations but also increased ROS (H2O2) and isoprostane (an index of lipid peroxidation), as well as depletion of NO center dot. Renal transcript analyses implicated changes in Nox1/2, Xo/Xdh, and Sod1,2 mRNAs in ROS elevation by the KO state. KO alterations in blood pressure, catecholamines, H2O2, isoprostane, and NO center dot could be abrogated or even normalized (rescued) by either sympathetic outflow inhibition (with clonidine) or NADPH oxidase inhibition (with apocynin). In cultured renal podocytes, H2O2 production was substantially augmented by epinephrine (probably through beta 2-adrenergic receptors) and modestly diminished by norepinephrine (probably through alpha(1)-adrenergic receptors).Conclusions-ROS appear to play a necessary role in the development of hyperadrenergic hypertension in this model, in a process mechanistically linking elevated blood pressure with catecholamine excess, renal transcriptional responses, ROS elevation, lipid peroxidation, and NO center dot depletion. Some of the changes appear to be dependent on transcription, whereas others are immediate. The cycle could be disrupted by inhibition of either sympathetic outflow or NADPH oxidase. Because common genetic variation at the human CHGA locus alters BP, the results have implications for antihypertensive treatment as well as prevention of target-organ consequences of the disease. The results document novel pathophysiological links between the adrenergic system and oxidative stress and suggest new strategies to probe the role and actions of ROS within this setting. (Circ Cardiovasc Genet. 2010;3:414-425.)

Abstract 303: Decreased Adrenomedullin and Interaction with NHE3 in Human GRK4 Γ 142v Transgenic Mice

Abstract 303: Decreased Adrenomedullin and Interaction with NHE3 in Human GRK4γ142v Transgenic Mice

Decreased renal protein expression of adrenomedullin and RAMP2 is associated with impaired pressure‐natriuresis in human GRK4γ 142V transgenic mice (1136.4)

Abstract 17594: Brain Microglial Cytokines are Critical for Renin-Angiotensin-Aldoterone-System(RAAS)-Induced Neurogenic Hypertension

Abstract 13013: Grk4-mediated Adiponectin Receptor-1 Phosphorylative Desensitization as a Novel Mechanism of Reduced Renal Sodium Excretion in Hypertension

Hypertension Induced by Nitric Oxide Synthase Inhibitor Increases Responsiveness of Ventricular Myocardium and Aorta of Rat Tissue to Adrenomedullin Stimulation in Vitro.

Adrenomedullin Inhibits Osmotic Water Permeability in Rat Inner Medullary Collecting Ducts

OXGR1-Dependent (Pro)Renin Receptor Upregulation in Collecting Ducts of the Clipped Kidney Contributes to Na+ Balance in Goldblatt Hypertensive Mice

Effect of GRK4 on renal gastrin receptor regulation in hypertension

Genetic Deletion of β-Arrestin 2 From the Subfornical Organ and Other Periventricular Nuclei in the Brain Alters Fluid Homeostasis and Blood Pressure

Abstract 12717: Enhance Negative Modulation of Beta 3 -Adrenergic Stimulation on Cardiomyocyte Functional Performance, [Ca 2+ ] i Regulation and β-Adrenergic Reserve in Rats Expressing Human Angiotensinogen Gene

Changes in Adrenomedullin and Receptor Activity-Modifying Protein 2 Mrna in Myocardium and Vessels During L-NNA-induced Hypertension in Rats

Relationship Between the Contents of Adrenomedullin and Distributions of Neutral Endopeptidase in Blood and Tissues of Spontaneously Hypertensive Rats

Role of Reactive Oxygen Species in Hyperadrenergic Hypertension Biochemical, Physiological, and Pharmacological Evidence from Targeted Ablation of the Chromogranin A (chga) Gene

Blood Pressure and Urinary Sodium Excretion in Relation to the A-1984G Adrenomedullin Polymorphism in a Chinese Population

Inhibition of Adenosine-1 Receptor-Mediated Preglomerular Vasoconstriction in AT1A Receptor-Deficient Mice.

The salt sensitivity of Drd4 -null mice is associated with the upregulations of sodium transporters in kidneys

Differential Expression of Components of the Cardiomyocyte Adrenomedullin/Intermedin Receptor System following Blood Pressure Reduction in Nitric Oxide-Deficient Hypertension

Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner

Inhibition of adenosine-1 receptor-mediated preglomerular vasoconstriction in ATreceptor-deficient mice.

Dysregulation of Cerebellar Adrenomedullin Signaling During Hypertension